The concordance between serum anti-Mullerian hormone and testosterone concentrations depends on duration of hCG stimulation in boys undergoing investigation of gonadal function
- PMID: 19811508
- DOI: 10.1111/j.1365-2265.2009.03724.x
The concordance between serum anti-Mullerian hormone and testosterone concentrations depends on duration of hCG stimulation in boys undergoing investigation of gonadal function
Abstract
Background: In boys undergoing investigation of gonadal function, the relationship between a single measurement of serum anti-Mullerian hormone (AMH) and hCG stimulated serum testosterone is unclear.
Aim: The aim of the study was to assess concordance between serum AMH and testosterone concentrations following hCG stimulation of two different durations.
Methods: Samples from 284 children (M : F, 154 : 130) with a median age of 8 years (10th, 90th centiles, 0.25, 14) were used to establish an AMH reference range. Clinical data were reviewed in boys undergoing investigation of gonadal function and who had an AMH measurement and a hCG stimulated (3-day or 3-week) (n = 26) testosterone. Of these 26 boys, 11 had combined genital anomalies, whereas the rest had conditions such as isolated hypospadias, undescended testes or microphallus. Normal testosterone response to hCG stimulation was defined as a level greater than 3.5 nmol at day 4 and 9.5 nmol/l at day 22.
Results: In the reference group, the 5th centile AMH for boys below 1 year was 215 pmol/l and between 1 and 8 years 180 pmol/l. The 95th centile for girls for these respective age groups was 30 pmol/l and 25 pmol/l. In those cases where serum testosterone concentrations were available at day 1, day 4 and day 22 of the 3 week-hCG test, five cases had a normal serum testosterone at day 4 and three cases only showed such a response by day 22. In those where serum AMH was less than 180 pmol/l, a poor testosterone response of less than 3.5 nmol was observed in approximately seven of eight (88%) cases with a 3-day hCG stimulation test or the 3-week test. An AMH of greater than 180 pmol/l was associated with a normal testosterone response at day 4 in 10 out of 15 (67%) cases and at day 22 in eight of 11 (73%) cases. However, a low serum testosterone concentration of less than 3.5 nmol after the 3-day hCG test was only associated with a likelihood of a low AMH in three of eight (37%) cases. With the 3-week hCG test, a low day 22 testosterone of 9.5 mmol/l or less was associated with a low AMH of 180 pmol/l or less in four of seven (57%) cases.
Conclusion: In boys undergoing investigation of gonadal function, the concordance between AMH and testosterone is better at day 22 than day 4. A normal AMH may provide useful information on overall testicular function but does not exclude the need for an hCG stimulation test.
Similar articles
-
Serum Anti-Müllerian Hormone in the Prediction of Response to hCG Stimulation in Children With DSD.J Clin Endocrinol Metab. 2020 May 1;105(5):1608-16. doi: 10.1210/clinem/dgaa052. J Clin Endocrinol Metab. 2020. PMID: 32016383 Free PMC article.
-
[Anti-Müllerian hormone (AMH) measurements in the assessment of testicular function in prepubertal boys and in sexual differentiation disorders].Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2006;12(3):195-9. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2006. PMID: 17020655 Polish.
-
Correlation of anti-Mullerian hormone with humanchorionic gonadotropin test in the evaluation of testicular function of children with 46 XY male hypogonadism: Use of anti-Mullerian hormone as abiomarker.J Paediatr Child Health. 2020 Mar;56(3):411-419. doi: 10.1111/jpc.14643. Epub 2019 Oct 15. J Paediatr Child Health. 2020. PMID: 31614067
-
Clinical use of anti-Müllerian hormone (AMH) determinations in patients with disorders of sex development: importance of sex- and age-specific reference ranges.Pediatr Endocrinol Rev. 2011 Sep;9 Suppl 1:525-8. Pediatr Endocrinol Rev. 2011. PMID: 22423510 Review.
-
MIS/AMH in the assessment of cryptorchidism and intersex conditions.Mol Cell Endocrinol. 2003 Dec 15;211(1-2):91-8. doi: 10.1016/j.mce.2003.09.014. Mol Cell Endocrinol. 2003. PMID: 14656481 Review.
Cited by
-
Diagnosis and management of non-CAH 46,XX disorders/differences in sex development.Front Endocrinol (Lausanne). 2024 May 15;15:1354759. doi: 10.3389/fendo.2024.1354759. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38812815 Free PMC article. Review.
-
Gonadal Function in Boys with Bilateral Undescended Testes.J Endocr Soc. 2023 Dec 12;8(2):bvad153. doi: 10.1210/jendso/bvad153. eCollection 2024 Jan 5. J Endocr Soc. 2023. PMID: 38205164 Free PMC article.
-
Dermatologic care of patients with differences of sex development.Int J Womens Dermatol. 2023 Sep 5;9(3):e106. doi: 10.1097/JW9.0000000000000106. eCollection 2023 Oct. Int J Womens Dermatol. 2023. PMID: 37671254 Free PMC article. Review.
-
Biomarkers of male hypogonadism in childhood and adolescence.Adv Lab Med. 2020 Apr 21;1(2):20200024. doi: 10.1515/almed-2020-0024. eCollection 2020 Jun. Adv Lab Med. 2020. PMID: 37363780 Free PMC article. Review.
-
The Variability and Determinants of Testosterone Measurements in Children: A Critical Review.Biol Res Nurs. 2021 Oct;23(4):646-657. doi: 10.1177/10998004211017323. Epub 2021 May 18. Biol Res Nurs. 2021. PMID: 34000839 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources